• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较两种用于中国一般人群的慢性阻塞性肺疾病筛查问卷的性能。

Comparing the Performance of Two Screening Questionnaires for Chronic Obstructive Pulmonary Disease in the Chinese General Population.

机构信息

Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China.

出版信息

Int J Chron Obstruct Pulmon Dis. 2023 Apr 10;18:541-552. doi: 10.2147/COPD.S403603. eCollection 2023.

DOI:10.2147/COPD.S403603
PMID:37065634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10103780/
Abstract

PURPOSE

Screening questionnaires can help identify individuals at a high risk of COPD. This study aimed to compare the performance of the COPD population screener (COPD-PS) and COPD screening questionnaire (COPD-SQ) on the general population as a full cohort and stratified by urbanization.

METHODS

We recruited subjects who underwent a health checkup at urban and rural community health centers in Beijing. All eligible subjects completed the COPD-PS and COPD-SQ, then spirometry. Spirometry-defined COPD was defined as a post-bronchodilator FEV/FVC<70%. Symptomatic COPD was defined as a post-bronchodilator FEV/FVC<70% and respiratory symptoms. Receiver operating characteristic (ROC) curve analysis compared the discriminatory power of the two questionnaires, and stratified by urbanization.

RESULTS

We identified 129 spirometry-defined and 92 symptomatic COPD cases out of 1350 enrolled subjects. The optimal cut-off score for the COPD-PS was 4 for spirometry-defined and 5 for symptomatic COPD. The optimum cut-off score for the COPD-SQ was 15 for both spirometry-defined and symptomatic COPD. The COPD-PS and COPD-SQ had similar AUC values for spirometry-defined (0.672 vs 0.702) and symptomatic COPD (0.734 vs 0.779). The AUC of the COPD-SQ tended to be higher in rural areas than that of the COPD-PS for spirometry-defined COPD (0.700 vs 0.653, = 0.093).

CONCLUSION

The COPD-PS and COPD-SQ had comparable discriminatory power for detecting COPD in the general population while the COPD-SQ performed better in rural areas. A pilot study for validating and comparing the diagnostic accuracy of different questionnaires is required when screening for COPD in a new environment.

摘要

目的

筛查问卷可帮助识别 COPD 高危人群。本研究旨在比较 COPD 人群筛查器(COPD-PS)和 COPD 筛查问卷(COPD-SQ)在一般人群中的表现,以及按城市化程度分层的表现。

方法

我们招募了在北京城市和农村社区卫生中心进行健康检查的受试者。所有符合条件的受试者均完成 COPD-PS 和 COPD-SQ 问卷,然后进行肺量测定。支气管扩张剂后 FEV/FVC<70%定义为肺量测定定义的 COPD。有症状的 COPD 定义为支气管扩张剂后 FEV/FVC<70%和呼吸系统症状。接收者操作特征(ROC)曲线分析比较了两种问卷的鉴别能力,并按城市化程度分层。

结果

我们从 1350 名入组受试者中确定了 129 例肺量测定定义的 COPD 和 92 例有症状的 COPD 病例。COPD-PS 的最佳截断值为肺量测定定义的 4 分和有症状的 COPD 的 5 分。COPD-SQ 的最佳截断值为肺量测定定义的和有症状的 COPD 均为 15 分。COPD-PS 和 COPD-SQ 对肺量测定定义的 COPD(0.672 对 0.702)和有症状的 COPD(0.734 对 0.779)的 AUC 值相似。COPD-SQ 在农村地区的 AUC 高于 COPD-PS 对于肺量测定定义的 COPD(0.700 对 0.653, = 0.093)。

结论

COPD-PS 和 COPD-SQ 对一般人群中 COPD 的检测具有相当的鉴别能力,而 COPD-SQ 在农村地区的表现更好。在新环境中进行 COPD 筛查时,需要进行验证和比较不同问卷诊断准确性的试点研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7768/10103780/cfb636dd80f5/COPD-18-541-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7768/10103780/e5164d33989d/COPD-18-541-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7768/10103780/0b07d5759595/COPD-18-541-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7768/10103780/cfb636dd80f5/COPD-18-541-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7768/10103780/e5164d33989d/COPD-18-541-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7768/10103780/0b07d5759595/COPD-18-541-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7768/10103780/cfb636dd80f5/COPD-18-541-g0003.jpg

相似文献

1
Comparing the Performance of Two Screening Questionnaires for Chronic Obstructive Pulmonary Disease in the Chinese General Population.比较两种用于中国一般人群的慢性阻塞性肺疾病筛查问卷的性能。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 10;18:541-552. doi: 10.2147/COPD.S403603. eCollection 2023.
2
Accuracy of Six Chronic Obstructive Pulmonary Disease Screening Questionnaires in the Chinese Population.六种慢性阻塞性肺疾病筛查问卷在中国人群中的准确性。
Int J Chron Obstruct Pulmon Dis. 2022 Feb 10;17:317-327. doi: 10.2147/COPD.S341648. eCollection 2022.
3
Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study.慢性阻塞性肺疾病筛查问卷的验证及日本普通人群诊断切点的确定:久山研究
Allergol Int. 2015 Jan;64(1):49-53. doi: 10.1016/j.alit.2014.06.002. Epub 2014 Dec 17.
4
Assessment of Five Questionnaires for Chronic Obstructive Pulmonary Disease in a Southern Italian Population: A Proof-of-Concept Study.评估五种问卷在意大利南部人群中对慢性阻塞性肺疾病的应用:概念验证研究。
Medicina (Kaunas). 2023 Jul 5;59(7):1252. doi: 10.3390/medicina59071252.
5
Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis.COPD 人群筛查问卷在 COPD 筛查中的表现:一项验证研究和荟萃分析。
Ann Med. 2021 Dec;53(1):1198-1206. doi: 10.1080/07853890.2021.1949486.
6
Efficacy of a Self-Designed Questionnaire for Community Screening of COPD.自拟问卷用于社区 COPD 筛查的效果。
Int J Chron Obstruct Pulmon Dis. 2022 Jun 14;17:1381-1391. doi: 10.2147/COPD.S359098. eCollection 2022.
7
Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study.日本普通人群中慢性阻塞性肺疾病人群筛查问卷与国际初级保健气道组问卷的比较:久山研究
Int J Chron Obstruct Pulmon Dis. 2016 Aug 16;11:1903-9. doi: 10.2147/COPD.S110429. eCollection 2016.
8
A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease.五项用于识别气流受限和慢性阻塞性肺疾病风险个体的调查的比较。
Respir Med. 2016 Nov;120:1-9. doi: 10.1016/j.rmed.2016.09.010. Epub 2016 Sep 15.
9
Combining case-finding methods for COPD in primary care: a large, two-stage design study.在初级保健中结合 COPD 的病例发现方法:一项大型两阶段设计研究。
Int J Tuberc Lung Dis. 2018 Jan 1;22(1):106-111. doi: 10.5588/ijtld.17.0334.
10
Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.《萨尔斯堡 COPD 筛查问卷(SCSQ)的制定和验证》:一项问卷制定和验证研究。
NPJ Prim Care Respir Med. 2017 Jan 26;27(1):4. doi: 10.1038/s41533-016-0005-7.

引用本文的文献

1
Impulse oscillometry-derived equation for prediction of abnormal FEV/FVC ratio for COPD screening in Chinese population: a multicenter cross-sectional study.基于脉冲振荡法推导的用于预测中国人群慢性阻塞性肺疾病筛查中异常FEV/FVC比值的方程:一项多中心横断面研究
Lancet Reg Health West Pac. 2025 Feb 26;56:101501. doi: 10.1016/j.lanwpc.2025.101501. eCollection 2025 Mar.
2
Cost-effectiveness of population-based screening for chronic obstructive pulmonary disease in China: a simulation modeling study.中国基于人群的慢性阻塞性肺疾病筛查的成本效益:一项模拟建模研究
Lancet Reg Health West Pac. 2024 Apr 29;46:101065. doi: 10.1016/j.lanwpc.2024.101065. eCollection 2024 May.
3

本文引用的文献

1
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.迈向消除慢性阻塞性肺疾病:柳叶刀委员会报告。
Lancet. 2022 Sep 17;400(10356):921-972. doi: 10.1016/S0140-6736(22)01273-9. Epub 2022 Sep 5.
2
Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年慢性阻塞性肺疾病负担及其可归因危险因素:2019 年全球疾病负担研究结果。
BMJ. 2022 Jul 27;378:e069679. doi: 10.1136/bmj-2021-069679.
3
Efficacy of a Self-Designed Questionnaire for Community Screening of COPD.
Screening performance of COPD-PS scale, COPD-SQ scale, peak expiratory flow, and their combinations for chronic obstructive pulmonary disease in the primary healthcare in Haicang District, Xiamen City.
慢性阻塞性肺疾病筛查问卷(COPD-PS)量表、慢性阻塞性肺疾病筛查问卷(COPD-SQ)量表、呼气峰值流速及其联合检测在厦门市海沧区基层医疗卫生机构对慢性阻塞性肺疾病的筛查效能
Front Med (Lausanne). 2024 Apr 9;11:1357077. doi: 10.3389/fmed.2024.1357077. eCollection 2024.
自拟问卷用于社区 COPD 筛查的效果。
Int J Chron Obstruct Pulmon Dis. 2022 Jun 14;17:1381-1391. doi: 10.2147/COPD.S359098. eCollection 2022.
4
Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement.慢性阻塞性肺疾病筛查:美国预防服务工作组重新确认推荐声明。
JAMA. 2022 May 10;327(18):1806-1811. doi: 10.1001/jama.2022.5692.
5
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?家庭空气污染与 COPD:是因果关系还是因贫困的其他方面而产生混淆?
Int J Tuberc Lung Dis. 2022 Mar 1;26(3):206-216. doi: 10.5588/ijtld.21.0570.
6
Accuracy of Six Chronic Obstructive Pulmonary Disease Screening Questionnaires in the Chinese Population.六种慢性阻塞性肺疾病筛查问卷在中国人群中的准确性。
Int J Chron Obstruct Pulmon Dis. 2022 Feb 10;17:317-327. doi: 10.2147/COPD.S341648. eCollection 2022.
7
Global burden of chronic obstructive pulmonary disease attributable to ambient particulate matter pollution and household air pollution from solid fuels from 1990 to 2019.2019 年,源于环境细颗粒物污染和固体燃料室内空气污染的全球慢性阻塞性肺疾病负担。
Environ Sci Pollut Res Int. 2022 May;29(22):32788-32799. doi: 10.1007/s11356-021-17732-8. Epub 2022 Jan 12.
8
Accuracy and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among primary care patients (≥40 years) in China: a cross-sectional screening test accuracy study: findings from the Breathe Well group.不同筛查策略在中国基层医疗患者(≥40 岁)中识别未诊断 COPD 的准确性和成本效益:一项横断面筛查试验准确性研究:Breathe Well 组的研究结果。
BMJ Open. 2021 Sep 23;11(9):e051811. doi: 10.1136/bmjopen-2021-051811.
9
Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis.COPD 人群筛查问卷在 COPD 筛查中的表现:一项验证研究和荟萃分析。
Ann Med. 2021 Dec;53(1):1198-1206. doi: 10.1080/07853890.2021.1949486.
10
[Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021)].慢性阻塞性肺疾病诊断和管理指南(2021年修订版)
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Mar 12;44(3):170-205. doi: 10.3760/cma.j.cn112147-20210109-00031.